0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Therapeutic Nuclear Medicines Market Research Report 2024
Published Date: February 2024
|
Report Code: QYRE-Auto-35P12757
Home | Market Reports | Health| Pharmacy
Global Therapeutic Nuclear Medicines Market Research Report 2023
BUY CHAPTERS

Global Therapeutic Nuclear Medicines Market Research Report 2024

Code: QYRE-Auto-35P12757
Report
February 2024
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Therapeutic Nuclear Medicines Market Size

The global Therapeutic Nuclear Medicines market was valued at US$ 1671 million in 2023 and is anticipated to reach US$ 5392 million by 2030, witnessing a CAGR of 18.0% during the forecast period 2024-2030.

Therapeutic Nuclear Medicines Market

Therapeutic Nuclear Medicines Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Global Therapeutic Nuclear Medicines key players include Bayer, Novartis AG, China Isotope & Radiation, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Radium-223 is the largest segment, with a share over 45%. And in terms of application, the largest application is Thyroid, followed by Bone Metastasis.
This report aims to provide a comprehensive presentation of the global market for Therapeutic Nuclear Medicines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Nuclear Medicines.

Report Scope

The Therapeutic Nuclear Medicines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic Nuclear Medicines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Nuclear Medicines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Therapeutic Nuclear Medicines Market Report

Report Metric Details
Report Name Therapeutic Nuclear Medicines Market
Accounted market size in 2023 US$ 1671 million
Forecasted market size in 2030 US$ 5392 million
CAGR 18.0%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radium-223
  • Lutetium-177
  • Iodine-131
  • Other
Segment by Application
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Therapeutic Nuclear Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Therapeutic Nuclear Medicines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Nuclear Medicines Market growing?

Ans: The Therapeutic Nuclear Medicines Market witnessing a CAGR of 18.0% during the forecast period 2024-2030.

What is the Therapeutic Nuclear Medicines Market size in 2030?

Ans: The Therapeutic Nuclear Medicines Market size in 2030 will be US$ 5392 million.

What is the market share of major companies in Therapeutic Nuclear Medicines Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Therapeutic Nuclear Medicines Market share by type?

Ans: In terms of product, Radium-223 is the largest segment, with a share over 45%.

Who are the main players in the Therapeutic Nuclear Medicines Market report?

Ans: The main players in the Therapeutic Nuclear Medicines Market are Novartis AG, Bayer, China Isotope & Radiation, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Dongcheng, Lantheus, Acrotech Biopharma., Progenics Pharmaceuticals, International Isotopes

What are the Application segmentation covered in the Therapeutic Nuclear Medicines Market report?

Ans: The Applications covered in the Therapeutic Nuclear Medicines Market report are Thyroid, Bone Metastasis, Lymphoma, Other

What are the Type segmentation covered in the Therapeutic Nuclear Medicines Market report?

Ans: The Types covered in the Therapeutic Nuclear Medicines Market report are Radium-223, Lutetium-177, Iodine-131, Other

1 Therapeutic Nuclear Medicines Market Overview
1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Therapeutic Nuclear Medicines Segment by Type
1.2.1 Global Therapeutic Nuclear Medicines Market Value Comparison by Type (2024-2030)
1.2.2 Radium-223
1.2.3 Lutetium-177
1.2.4 Iodine-131
1.2.5 Other
1.3 Therapeutic Nuclear Medicines Segment by Application
1.3.1 Global Therapeutic Nuclear Medicines Market Value by Application: (2024-2030)
1.3.2 Thyroid
1.3.3 Bone Metastasis
1.3.4 Lymphoma
1.3.5 Other
1.4 Global Therapeutic Nuclear Medicines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic Nuclear Medicines Revenue 2019-2030
1.4.2 Global Therapeutic Nuclear Medicines Sales 2019-2030
1.4.3 Global Therapeutic Nuclear Medicines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic Nuclear Medicines Market Competition by Manufacturers
2.1 Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic Nuclear Medicines Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic Nuclear Medicines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic Nuclear Medicines, Product Type & Application
2.7 Therapeutic Nuclear Medicines Market Competitive Situation and Trends
2.7.1 Therapeutic Nuclear Medicines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic Nuclear Medicines Players Market Share by Revenue
2.7.3 Global Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic Nuclear Medicines Retrospective Market Scenario by Region
3.1 Global Therapeutic Nuclear Medicines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic Nuclear Medicines Global Therapeutic Nuclear Medicines Sales by Region: 2019-2030
3.2.1 Global Therapeutic Nuclear Medicines Sales by Region: 2019-2024
3.2.2 Global Therapeutic Nuclear Medicines Sales by Region: 2025-2030
3.3 Global Therapeutic Nuclear Medicines Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2030
3.3.1 Global Therapeutic Nuclear Medicines Revenue by Region: 2019-2024
3.3.2 Global Therapeutic Nuclear Medicines Revenue by Region: 2025-2030
3.4 North America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.4.1 North America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
3.4.3 North America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.5.1 Europe Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic Nuclear Medicines Sales by Country (2019-2030)
3.5.3 Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic Nuclear Medicines Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.7.1 Latin America Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic Nuclear Medicines Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic Nuclear Medicines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic Nuclear Medicines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic Nuclear Medicines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2030)
4.1.1 Global Therapeutic Nuclear Medicines Sales by Type (2019-2024)
4.1.2 Global Therapeutic Nuclear Medicines Sales by Type (2025-2030)
4.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic Nuclear Medicines Revenue by Type (2019-2030)
4.2.1 Global Therapeutic Nuclear Medicines Revenue by Type (2019-2024)
4.2.2 Global Therapeutic Nuclear Medicines Revenue by Type (2025-2030)
4.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic Nuclear Medicines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2030)
5.1.1 Global Therapeutic Nuclear Medicines Sales by Application (2019-2024)
5.1.2 Global Therapeutic Nuclear Medicines Sales by Application (2025-2030)
5.1.3 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic Nuclear Medicines Revenue by Application (2019-2030)
5.2.1 Global Therapeutic Nuclear Medicines Revenue by Application (2019-2024)
5.2.2 Global Therapeutic Nuclear Medicines Revenue by Application (2025-2030)
5.2.3 Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic Nuclear Medicines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis AG Therapeutic Nuclear Medicines Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Therapeutic Nuclear Medicines Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 China Isotope & Radiation
6.3.1 China Isotope & Radiation Corporation Information
6.3.2 China Isotope & Radiation Description and Business Overview
6.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 China Isotope & Radiation Therapeutic Nuclear Medicines Product Portfolio
6.3.5 China Isotope & Radiation Recent Developments/Updates
6.4 Q BioMed
6.4.1 Q BioMed Corporation Information
6.4.2 Q BioMed Description and Business Overview
6.4.3 Q BioMed Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Q BioMed Therapeutic Nuclear Medicines Product Portfolio
6.4.5 Q BioMed Recent Developments/Updates
6.5 Curium Pharmaceuticals
6.5.1 Curium Pharmaceuticals Corporation Information
6.5.2 Curium Pharmaceuticals Description and Business Overview
6.5.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.5.5 Curium Pharmaceuticals Recent Developments/Updates
6.6 Jubilant DraxImage
6.6.1 Jubilant DraxImage Corporation Information
6.6.2 Jubilant DraxImage Description and Business Overview
6.6.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jubilant DraxImage Therapeutic Nuclear Medicines Product Portfolio
6.6.5 Jubilant DraxImage Recent Developments/Updates
6.7 Dongcheng
6.6.1 Dongcheng Corporation Information
6.6.2 Dongcheng Description and Business Overview
6.6.3 Dongcheng Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dongcheng Therapeutic Nuclear Medicines Product Portfolio
6.7.5 Dongcheng Recent Developments/Updates
6.8 Lantheus
6.8.1 Lantheus Corporation Information
6.8.2 Lantheus Description and Business Overview
6.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Lantheus Therapeutic Nuclear Medicines Product Portfolio
6.8.5 Lantheus Recent Developments/Updates
6.9 Acrotech Biopharma.
6.9.1 Acrotech Biopharma. Corporation Information
6.9.2 Acrotech Biopharma. Description and Business Overview
6.9.3 Acrotech Biopharma. Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Acrotech Biopharma. Therapeutic Nuclear Medicines Product Portfolio
6.9.5 Acrotech Biopharma. Recent Developments/Updates
6.10 Progenics Pharmaceuticals
6.10.1 Progenics Pharmaceuticals Corporation Information
6.10.2 Progenics Pharmaceuticals Description and Business Overview
6.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Portfolio
6.10.5 Progenics Pharmaceuticals Recent Developments/Updates
6.11 International Isotopes
6.11.1 International Isotopes Corporation Information
6.11.2 International Isotopes Therapeutic Nuclear Medicines Description and Business Overview
6.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 International Isotopes Therapeutic Nuclear Medicines Product Portfolio
6.11.5 International Isotopes Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic Nuclear Medicines Industry Chain Analysis
7.2 Therapeutic Nuclear Medicines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic Nuclear Medicines Production Mode & Process
7.4 Therapeutic Nuclear Medicines Sales and Marketing
7.4.1 Therapeutic Nuclear Medicines Sales Channels
7.4.2 Therapeutic Nuclear Medicines Distributors
7.5 Therapeutic Nuclear Medicines Customers
8 Therapeutic Nuclear Medicines Market Dynamics
8.1 Therapeutic Nuclear Medicines Industry Trends
8.2 Therapeutic Nuclear Medicines Market Drivers
8.3 Therapeutic Nuclear Medicines Market Challenges
8.4 Therapeutic Nuclear Medicines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Therapeutic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Therapeutic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Therapeutic Nuclear Medicines Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Therapeutic Nuclear Medicines Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Therapeutic Nuclear Medicines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Therapeutic Nuclear Medicines, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Therapeutic Nuclear Medicines, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Therapeutic Nuclear Medicines, Product Type & Application
    Table 12. Global Key Manufacturers of Therapeutic Nuclear Medicines, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Therapeutic Nuclear Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Nuclear Medicines as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Therapeutic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
    Table 18. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2019-2024)
    Table 19. Global Therapeutic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
    Table 20. Global Therapeutic Nuclear Medicines Sales Market Share by Region (2025-2030)
    Table 21. Global Therapeutic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2019-2024)
    Table 23. Global Therapeutic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2025-2030)
    Table 25. North America Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
    Table 27. North America Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
    Table 28. North America Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Therapeutic Nuclear Medicines Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Therapeutic Nuclear Medicines Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2019-2024)
    Table 51. Global Therapeutic Nuclear Medicines Sales (K Units) by Type (2025-2030)
    Table 52. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2019-2024)
    Table 53. Global Therapeutic Nuclear Medicines Sales Market Share by Type (2025-2030)
    Table 54. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2019-2024)
    Table 57. Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2025-2030)
    Table 58. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2019-2024)
    Table 61. Global Therapeutic Nuclear Medicines Sales (K Units) by Application (2025-2030)
    Table 62. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2019-2024)
    Table 63. Global Therapeutic Nuclear Medicines Sales Market Share by Application (2025-2030)
    Table 64. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Therapeutic Nuclear Medicines Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2019-2024)
    Table 67. Global Therapeutic Nuclear Medicines Revenue Market Share by Application (2025-2030)
    Table 68. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2025-2030)
    Table 70. Novartis AG Corporation Information
    Table 71. Novartis AG Description and Business Overview
    Table 72. Novartis AG Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Novartis AG Therapeutic Nuclear Medicines Product
    Table 74. Novartis AG Recent Developments/Updates
    Table 75. Bayer Corporation Information
    Table 76. Bayer Description and Business Overview
    Table 77. Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Bayer Therapeutic Nuclear Medicines Product
    Table 79. Bayer Recent Developments/Updates
    Table 80. China Isotope & Radiation Corporation Information
    Table 81. China Isotope & Radiation Description and Business Overview
    Table 82. China Isotope & Radiation Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. China Isotope & Radiation Therapeutic Nuclear Medicines Product
    Table 84. China Isotope & Radiation Recent Developments/Updates
    Table 85. Q BioMed Corporation Information
    Table 86. Q BioMed Description and Business Overview
    Table 87. Q BioMed Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Q BioMed Therapeutic Nuclear Medicines Product
    Table 89. Q BioMed Recent Developments/Updates
    Table 90. Curium Pharmaceuticals Corporation Information
    Table 91. Curium Pharmaceuticals Description and Business Overview
    Table 92. Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Curium Pharmaceuticals Therapeutic Nuclear Medicines Product
    Table 94. Curium Pharmaceuticals Recent Developments/Updates
    Table 95. Jubilant DraxImage Corporation Information
    Table 96. Jubilant DraxImage Description and Business Overview
    Table 97. Jubilant DraxImage Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Jubilant DraxImage Therapeutic Nuclear Medicines Product
    Table 99. Jubilant DraxImage Recent Developments/Updates
    Table 100. Dongcheng Corporation Information
    Table 101. Dongcheng Description and Business Overview
    Table 102. Dongcheng Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Dongcheng Therapeutic Nuclear Medicines Product
    Table 104. Dongcheng Recent Developments/Updates
    Table 105. Lantheus Corporation Information
    Table 106. Lantheus Description and Business Overview
    Table 107. Lantheus Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Lantheus Therapeutic Nuclear Medicines Product
    Table 109. Lantheus Recent Developments/Updates
    Table 110. Acrotech Biopharma. Corporation Information
    Table 111. Acrotech Biopharma. Description and Business Overview
    Table 112. Acrotech Biopharma. Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Acrotech Biopharma. Therapeutic Nuclear Medicines Product
    Table 114. Acrotech Biopharma. Recent Developments/Updates
    Table 115. Progenics Pharmaceuticals Corporation Information
    Table 116. Progenics Pharmaceuticals Description and Business Overview
    Table 117. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product
    Table 119. Progenics Pharmaceuticals Recent Developments/Updates
    Table 120. International Isotopes Corporation Information
    Table 121. International Isotopes Description and Business Overview
    Table 122. International Isotopes Therapeutic Nuclear Medicines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 123. International Isotopes Therapeutic Nuclear Medicines Product
    Table 124. International Isotopes Recent Developments/Updates
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Therapeutic Nuclear Medicines Distributors List
    Table 128. Therapeutic Nuclear Medicines Customers List
    Table 129. Therapeutic Nuclear Medicines Market Trends
    Table 130. Therapeutic Nuclear Medicines Market Drivers
    Table 131. Therapeutic Nuclear Medicines Market Challenges
    Table 132. Therapeutic Nuclear Medicines Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Therapeutic Nuclear Medicines
    Figure 2. Global Therapeutic Nuclear Medicines Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Therapeutic Nuclear Medicines Market Share by Type in 2023 & 2030
    Figure 4. Radium-223 Product Picture
    Figure 5. Lutetium-177 Product Picture
    Figure 6. Iodine-131 Product Picture
    Figure 7. Other Product Picture
    Figure 8. Global Therapeutic Nuclear Medicines Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Therapeutic Nuclear Medicines Market Share by Application in 2023 & 2030
    Figure 10. Thyroid
    Figure 11. Bone Metastasis
    Figure 12. Lymphoma
    Figure 13. Other
    Figure 14. Global Therapeutic Nuclear Medicines Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Therapeutic Nuclear Medicines Market Size (2019-2030) & (US$ Million)
    Figure 16. Global Therapeutic Nuclear Medicines Sales (2019-2030) & (K Units)
    Figure 17. Global Therapeutic Nuclear Medicines Average Price (USD/Unit) & (2019-2030)
    Figure 18. Therapeutic Nuclear Medicines Report Years Considered
    Figure 19. Therapeutic Nuclear Medicines Sales Share by Manufacturers in 2023
    Figure 20. Global Therapeutic Nuclear Medicines Revenue Share by Manufacturers in 2023
    Figure 21. The Global 5 and 10 Largest Therapeutic Nuclear Medicines Players: Market Share by Revenue in 2023
    Figure 22. Therapeutic Nuclear Medicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 23. Global Therapeutic Nuclear Medicines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 24. North America Therapeutic Nuclear Medicines Sales Market Share by Country (2019-2030)
    Figure 25. North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2019-2030)
    Figure 26. U.S. Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. Canada Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2019-2030)
    Figure 29. Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2019-2030)
    Figure 30. Germany Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. France Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. U.K. Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Italy Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Russia Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Therapeutic Nuclear Medicines Sales Market Share by Region (2019-2030)
    Figure 36. Asia Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region (2019-2030)
    Figure 37. China Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Japan Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. South Korea Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. India Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Australia Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Taiwan Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Indonesia Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Thailand Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Malaysia Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Philippines Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Latin America Therapeutic Nuclear Medicines Sales Market Share by Country (2019-2030)
    Figure 48. Latin America Therapeutic Nuclear Medicines Revenue Market Share by Country (2019-2030)
    Figure 49. Mexico Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 50. Brazil Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Argentina Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2019-2030)
    Figure 53. Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2019-2030)
    Figure 54. Turkey Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 56. UAE Therapeutic Nuclear Medicines Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Global Sales Market Share of Therapeutic Nuclear Medicines by Type (2019-2030)
    Figure 58. Global Revenue Market Share of Therapeutic Nuclear Medicines by Type (2019-2030)
    Figure 59. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Type (2019-2030)
    Figure 60. Global Sales Market Share of Therapeutic Nuclear Medicines by Application (2019-2030)
    Figure 61. Global Revenue Market Share of Therapeutic Nuclear Medicines by Application (2019-2030)
    Figure 62. Global Therapeutic Nuclear Medicines Price (USD/Unit) by Application (2019-2030)
    Figure 63. Therapeutic Nuclear Medicines Value Chain
    Figure 64. Therapeutic Nuclear Medicines Production Process
    Figure 65. Channels of Distribution (Direct Vs Distribution)
    Figure 66. Distributors Profiles
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Paroxetine Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36M7629
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Felodipine Sustained-Release Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36A7630
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Sertraline Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25H7597
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Escitalopram Oxalate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11E7869
Thu Mar 28 00:00:00 UTC 2024

Add to Cart